Xeos
PrivateLast Round
Accelerator
May 27, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Xeos operates in Healthcare & Life Sciences and is based in Belgium. Its latest recorded funding round was an Accelerator round in May 2026.
Xeos is a medical technology company that develops intraoperative molecular imaging solutions, including the AURA 10 PET-CT specimen imager, to improve surgical oncology outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xeos Comparables
Compare Xeos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SamanTree Medical | 85% | |
| KUBTEC Medical Imaging | 81% | |
| Perimeter Medical Imaging AI Inc | 80% |
For institutional investors. Book with your work email.
Xeos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 27, 2026 | ||||
| VC Round | Jan 9, 2026 | ||||
| Grant | Mar 20, 2024 | ||||
| VC Round | Jan 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Xeos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 306% MoM.
- May 27, 2026
Received funding from MedTech Innovator.
For institutional investors. Book with your work email.
Xeos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xeos's valuation, stock price, and market status.
Is Xeos a public or private company?
Xeos is a private company.
What is the current stock price of Xeos?
Xeos is a private company, so its shares have no public market price. Caplight tracks Xeos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xeos worth (valuation)?
Valuation information for Xeos is not publicly available.
Can I buy Xeos stock?
Xeos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xeos's last funding round?
Xeos's most recent funding round was Accelerator on May 27, 2026.
Who are the main investors in Xeos?
Key investors in Xeos include MedTech Innovator.
Will Xeos IPO soon?
No public IPO plans have been announced for Xeos.
How can I track Xeos secondary market activity?
Caplight tracks bids, offers, and trades in Xeos's shares on secondary markets.